CRSPCRISPR Therapeutics AGBasingEarnings in 13 days

TodayBasingjumpy stock

Nasdaq GMBiotechnologyMarket cap $4.74BReports Nov 9, 2026

CRISPR Therapeutics AG

Gene therapy
Sector
Healthcare
Industry
Biotechnology
Market cap
$4.74B
Employees
393
Exchange
Nasdaq GM
Country
Switzerland
49.01−0.77% todayClose of Oct 26, 2026 · end-of-day snapshot

Not sure what's inside? Read a full TSLA analysis, currently free

Figures as of Oct 26, 2026Unlock all 8$9.90one-time

Technical readingsFree

Trend state Basing, stage 1 of 4, 3 of 4 damage flags raised (as of Oct 26, 2026)

Automated read

The moving-average structure shows no decisive trend in either direction: the mid-term picture reads as rangebound. RSI is currently 40.

Readings, end-of-day Oct 26, 2026
RSI (14)Lower-neutral39.51, caution reading
MACD / signalBelow signal line-1.45 / -1.24, caution reading
SMA 50Price below54.47, caution reading
SMA 200Price below52.94, caution reading
EMA 20Price below51.50, caution reading
ADX (14)Rangebound13.18
Show all 12 readings
+DI / −DI−DI leading17.00 / 22.78
ATR (14)4.5% of price — typical daily swing2.21
Stochastic %KMid-range22.82
Bollinger bands (20)Inside bands46.77 – 57.34
ROC (10)Negative over 10 sessions-4.93, caution reading
Trend / momentum impulseTrend and momentum disagreeMixed
Full analysis

What unlocking CRSP reveals

Company & theme write-upWhat the company does, the themes it belongs to, and the tags that place it beside its peers.Generated on unlock
Signal historyEvery past volume signal measured forward from the day it fired.Generated on unlock
AI narrativeThe volume, technical and fundamental reads tied into one plain-language story.Generated on unlock
Catalysts & risksScheduled events set beside the risks the narrative flags, each paired to its figure.Generated on unlock
Accumulation readVolume measured against this stock's own baseline, broken down day by day.Generated on unlock

Generated on unlock: written when CRSP's analysis runs, rather than checked against its stored data now.

Every section above, argued on CRSP's own numbers, on one page.

See what CRSP costsNot sure what's inside? Read a full TSLA analysis, currently free

Unlock the full CRSP analysis

AI narrative, signals and history, social sentiment and the full fundamentals, refreshed each market day for 30 days.

  • Unlocked in about 60 seconds
  • No account needed
  • Secure checkout via Stripe

Covering a bigger list? Get 15 for $49.00: one-time, 30 days for the whole pack, swaps included.

Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get CRSP + ~23,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
Earnings

When does CRISPR Therapeutics AG report earnings?

CRISPR Therapeutics AG (CRSP) is scheduled to report earnings on Nov 9, 2026.

The date is confirmed rather than estimated, though companies do occasionally reschedule.

Data as of Oct 27, 2026

See who else reports soon
Data dictionary
$9.90one-time Unlock CRSP